SEC Filing Madrigal Pharmaceuticals.
$ 13.00 · 4.9 (512) · In stock
SEC Filing Deciphera Pharmaceuticals, Inc.
Overview Madrigal Pharmaceuticals.
SEC Filing
SEC Filing Madrigal Pharmaceuticals.
Conshohocken-based Madrigal Pharmceuticals plans a $500M stock sale - Philadelphia Business Journal
g560783.jpg
Madrigal Pharmaceuticals: Odds Shortening On NASH Drug Approval (NASDAQ:MDGL)
ETFs Holding MDGL, Madrigal Pharmaceuticals Inc
SEC Filing
EDGAR Filing Documents for 0001193125-24-004269